Immediate Impact
41 standout
Citing Papers
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
2022 Standout
A green and sensitive guanine-based DNA biosensor for idarubicin anticancer monitoring in biological samples: A simple and fast strategy for control of health quality in chemotherapy procedure confirmed by docking investigation
2021 Standout
Works of R. Mozzana being referenced
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.
1989
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R. Mozzana | 68 | 84 | 54 | 67 | 24 | 194 | |
| Eduardo Ríos | 69 | 104 | 73 | 71 | 32 | 214 | |
| Ruemu Birhiray | 69 | 79 | 78 | 81 | 30 | 233 | |
| Leyre Bento | 88 | 86 | 76 | 48 | 31 | 229 | |
| Atsuko Mugitani | 90 | 53 | 77 | 35 | 28 | 214 | |
| Kiyomi Mashima | 80 | 46 | 43 | 41 | 27 | 196 | |
| Silvia Imbergamo | 79 | 62 | 42 | 118 | 19 | 218 | |
| Pierangelo Spedini | 131 | 81 | 53 | 131 | 16 | 268 | |
| Bernard De Prijck | 93 | 94 | 64 | 104 | 24 | 223 | |
| Ana Isabel Teruel | 75 | 59 | 57 | 53 | 24 | 188 | |
| Güner Hayri Özsan | 86 | 51 | 80 | 32 | 31 | 217 |
All Works
Loading papers...